Success Metrics

Clinical Success Rate
41.2%

Based on 7 completed trials

Completion Rate
41%(7/17)
Active Trials
1(6%)
Results Posted
214%(15 trials)
Terminated
10(56%)

Phase Distribution

Ph phase_3
10
56%
Ph phase_1
2
11%
Ph phase_2
6
33%

Phase Distribution

2

Early Stage

6

Mid Stage

10

Late Stage

Phase Distribution18 total trials
Phase 1Safety & dosage
2(11.1%)
Phase 2Efficacy & side effects
6(33.3%)
Phase 3Large-scale testing
10(55.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

41.2%

7 of 17 finished

Non-Completion Rate

58.8%

10 ended early

Currently Active

1

trials recruiting

Total Trials

18

all time

Status Distribution
Active(1)
Completed(7)
Terminated(10)

Detailed Status

Terminated10
Completed7
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
18
Active
1
Success Rate
41.2%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (11.1%)
Phase 26 (33.3%)
Phase 310 (55.6%)

Trials by Status

active_not_recruiting16%
completed739%
terminated1056%

Recent Activity

Clinical Trials (18)

Showing 18 of 18 trials
NCT04163419Phase 2

Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis

Active Not Recruiting
NCT02609828Phase 3

Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy

Completed
NCT00999518Phase 2

A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome

Terminated
NCT00809354Phase 3

Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip

Terminated
NCT00826514Phase 2

An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis

Completed
NCT00809783Phase 3

Extension Study Of Tanezumab In Osteoarthritis

Terminated
NCT00784693Phase 2

A Clinical Study To Investigate The Effectiveness And Safety Of Tanezumab In Treating Pain Associated With Endometriosis

Terminated
NCT01146561Phase 2

Safety And Efficacy Of Tanezumab In Patients With Chronic Pancreatitis

Terminated
NCT00733902Phase 3

Tanezumab in Osteoarthritis of the Knee

Completed
NCT01127893Phase 3

Safety Extension Study Of Tanezumab When Administered By Subcutaneous Injection To Patients With Osteoarthritis

Terminated
NCT00744471Phase 3

Tanezumab in Osteoarthritis Of The Hip

Completed
NCT00864097Phase 3

Analgesic Efficacy And Safety of Tanezumab Added On To Diclofenac SR In Patients With Osteoarthritis Of The Knee Or Hip

Terminated
NCT01087203Phase 2

A Study Of The Analgesic (Pain-Relief) Effects Of Tanezumab In Adult Patients With Diabetic Peripheral Neuropathy

Terminated
NCT00960804Phase 3

Long-Term Study Of The Safety Of Tanezumab In Arthritis Patients

Terminated
NCT00863772Phase 3

Tanezumab and Nerve Function In Arthritis Patients

Terminated
NCT00788294Phase 1

Measure Exposure Of Tanezumab In Healthy Volunteers When Administering The Drug Subcutaneously

Completed
NCT02709486Phase 3

Study of the Analgesic Efficacy and Safety of Subcutaneous Tanezumab in Subjects With Osteoarthritis of the Hip or Knee.

Completed
NCT01030640Phase 1

Study To Assess Changes In The Number Of Nerves In The Skin At The Site Where Where Tanezumab Is Injected

Completed

All 18 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
18